Liu, J., Fu, Y., Wang, B., Li, Z., Wang, Y., Zhang, J., Yi, T., Deng, Y., Jiang, Y. (2025). Eribulin plus anlotinib in advanced soft tissue sarcoma (ERAS): Updates on efficacy and biomarkers.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.11502